Vitaeris Inc.
Industry
- Biotechnology
- Large Molecule
- Antibodies
- Large Molecule
- Pharmaceuticals
Latest on Vitaeris Inc.
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. GSK Teams With Ideaya On Synthetic Leth
CSL Ltd. is not a typical biopharmaceutical company, given its plasma collection business and plasma-derived product expertise, but it has the same goal as many of its peers – to bring in more exter
The EU's scientific advisory panel, the Committee for Medicinal Products for Human Use (CHMP), has confirmed that Janssen-Cilag International has withdrawn its EU marketing application for the int
IN VITRO DIAGNOSTICS Mergers & Acquisitions Luminex Corp. Nanosphere Inc. Luminex Corp. is paying $77mm ($1.70 per share; a 63% premium) in cash to acquire molecular diagnostics firm Nanosphere